JPMorgan analyst Jessica Fye upgraded Crinetics (NASDAQ: CRNX) from Overweight to Overweight with a price target of $28.00 (from $22.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE